- Filed
- Nov 15, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Oct 31, 2021 | 600.09K sh |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $1.01M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $996.27K |
| Total Assets | Q3 2021 · Sep 30, 2021 | $3.99M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $5.6M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $4.75M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $5.41M |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 600.09K sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 600.09K sh |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | −$1.18M |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | $5.18M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | $5.44M |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | $5.75M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | $6.04M |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.44 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$1.43 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.44 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$1.43 |
| Sga Expense restated | Q3 2021 · Sep 30, 2020 | $264.09K |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $922.17K |
| Net Income | Q3 2021 · Sep 30, 2020 | −$264.18K |
| Net Income | Q3 2021 · Sep 30, 2020 | −$857.03K |
| Net Income | Q3 2021 · Jun 30, 2020 | −$310.4K |
| Net Income | Q3 2021 · Mar 31, 2020 | −$282.45K |
| Revenue restated | Q3 2021 · Sep 30, 2020 | $1.07M |
| Revenue restated | Q3 2021 · Sep 30, 2020 | $3.57M |